Democrats believed open to regulating generic biotech drugs

11/13/2006 | Los Angeles Times (tiered subscription model)

The new Democrat-controlled Congress may be friendlier to the idea of creating legislation allowing generic versions of biotech drugs. The list of biotech products with expired patents is expected to grow over the next several years, and biotech companies say their medicines are too complicated to replicate safely and effectively.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ